Advertisement
Advertisement

KPTI

KPTI logo

Karyopharm Therapeutics Inc.

8.64
USD
Sponsored
-0.21
-2.37%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

8.39

-0.25
-2.94%

Karyopharm Therapeutics Inc. Profile

About

Karyopharm Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs for the treatment of cancer and other major diseases. It serves the healthcare industry throughout the United States. Karyopharm Therapeutics, Inc. is based in United States.

Info & Links

CEO

Richard Paulson

Headquarters

85 WELLS AVENUE, SECOND FLOOR
NEWTON, MA 02459, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.karyopharm.com

Auditor

Ernst & Young LLP

Share holders

16

Employees

228

Karyopharm Therapeutics Inc. Statistics

Valuation Measures

Market Capitalization2

189.11M

Enterprise Value

355.47M

Enterprise Value/EBITDA(ttm)

-4.43

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

1.02

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

95.94%

Operating Margin(ttm)

-91.52%

Profit Margin(ttm)

-137.87%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

242.16%

Return on Assets(ttm)

-122.29%

Income Statement

Revenue(ttm)

146.07M

Revenue Per Share(ttm)

7.96

Gross Profit(ttm)

140.12M

EBITDA(ttm)3

-80.28M

Net Income Available to Common(ttm)

-196.04M

Diluted EPS(ttm)

-16.62

Share Statistics

Beta (5Y Monthly)

0.40

52-Week Change

40.49%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

18.34M

Dividend Yield

0.00%

Float4

18.06M

% Held by Insiders

1.53%

% Held by Institutions

66.44%

Balance Sheet

Total Cash(mrq)

63.74M

Total Cash Per Share(mrq)

3.47

Total Debt(mrq)

226.90M

Total Debt/Equity(mrq)

-77.46%

Current Ratio(mrq)

1.12%

Quick Ratio(mrq)

1.08%

Book Value Per Share(mrq)

-16.00

Cash Flow

Operating Cash Flow Per Share(ytd)

-6.89

Free Cash Flow(ytd)

-75.37M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement